Direct upregulation of Bak or indirect alteration of its related interaction molecules will be therapeutically beneficial for overcoming Taxol resistance in breast cancer particularly in HER2-positive and hormone-positive cases. This evidence concerns the gene ERBB2 and breast carcinoma.